Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 04, 2024 09:00 ET | Source: Oncternal Therapeutics

Oncternal Therapeutics Announces Reverse Stock Split

SAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today...
January 02, 2024 09:00 ET | Source: Oncternal Therapeutics

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today...
December 26, 2023 09:00 ET | Source: Oncternal Therapeutics

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma

SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today...
December 22, 2023 04:03 ET | Source: Research and Markets

RNA Sequencing Global Market Report, Featuring 10X Genomics, Agilent Technologies, Illumina, Oxford Nanopore Technologies, Pacific Biosciences, Takara Bio, Tecan and Thermo Fisher Scientific

Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Market for RNA Sequencing, 3rd Edition" report has been added to ResearchAndMarkets.com's offering. The sequencing market has continued to provide...
December 04, 2023 09:12 ET | Source: Emergen Research

Smart Irrigation Market Size Worth USD 6,978.05 Billion in 2032 | Emergen Research

Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global smart irrigation market size reached USD 1,476.3 Million in 2021 and is expected to register a revenue CAGR of 15.2% during the forecast...
November 13, 2023 06:00 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Presents Successful Structure and Pain Results from Completed Phase 3 Long-Term Extension Clinical Trial for Lorecivivint for the Treatment of Knee Osteoarthritis

Biosplice Therapeutics Inc. presents results of OA-07 Long-Term Extension Trial for its knee OA drug candidate, lorecivivint.
November 09, 2023 16:01 ET | Source: Oncternal Therapeutics

Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

The first patient was dosed in our Phase 1/2 study for ONCT-534, our dual-action androgen receptor inhibitor, for the treatment of patients with advanced prostate cancer who are resistant to approved...
November 02, 2023 16:05 ET | Source: Oncternal Therapeutics

Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today...
October 26, 2023 09:00 ET | Source: Oncternal Therapeutics

Oncternal Therapeutics Announces FDA Granted Fast Track Designation for ONCT-534 for the Treatment of Metastatic Castration-Resistant Prostate Cancer

SAN DIEGO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today...
October 26, 2023 08:30 ET | Source: Duck Creek Technologies

Duck Creek Technologies Emphasizes Significance of Powerful Partner Ecosystem at ITC Vegas

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, is gearing up for...